Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080]

Bibliographic Details
Main Authors: Chong Yuan, Kaili Chang, Chenyue Xu, Qingquan Li, Zunguo Du
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Translational Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523321001121
_version_ 1819064560798138368
author Chong Yuan
Kaili Chang
Chenyue Xu
Qingquan Li
Zunguo Du
author_facet Chong Yuan
Kaili Chang
Chenyue Xu
Qingquan Li
Zunguo Du
author_sort Chong Yuan
collection DOAJ
first_indexed 2024-12-21T15:32:31Z
format Article
id doaj.art-82e32564086041a19fbffe2606b84bdb
institution Directory Open Access Journal
issn 1936-5233
language English
last_indexed 2024-12-21T15:32:31Z
publishDate 2021-08-01
publisher Elsevier
record_format Article
series Translational Oncology
spelling doaj.art-82e32564086041a19fbffe2606b84bdb2022-12-21T18:58:44ZengElsevierTranslational Oncology1936-52332021-08-01148101120Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080]Chong Yuan0Kaili Chang1Chenyue Xu2Qingquan Li3Zunguo Du4Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, ChinaDepartment of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, ChinaDepartment of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, ChinaDepartment of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China; Corresponding authors.Department of pathology, Huashan hospital, Fudan university, No.12 Middle Urumqi road, Shanghai, 200032, China; Corresponding authors.http://www.sciencedirect.com/science/article/pii/S1936523321001121
spellingShingle Chong Yuan
Kaili Chang
Chenyue Xu
Qingquan Li
Zunguo Du
Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080]
Translational Oncology
title Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080]
title_full Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080]
title_fullStr Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080]
title_full_unstemmed Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080]
title_short Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080]
title_sort corrigendum to high expression of dll3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients translational oncology 14 2021 101080
url http://www.sciencedirect.com/science/article/pii/S1936523321001121
work_keys_str_mv AT chongyuan corrigendumtohighexpressionofdll3isassociatedwithapoorprognosisandimmuneinfiltrationininvasivebreastcancerpatientstranslationaloncology142021101080
AT kailichang corrigendumtohighexpressionofdll3isassociatedwithapoorprognosisandimmuneinfiltrationininvasivebreastcancerpatientstranslationaloncology142021101080
AT chenyuexu corrigendumtohighexpressionofdll3isassociatedwithapoorprognosisandimmuneinfiltrationininvasivebreastcancerpatientstranslationaloncology142021101080
AT qingquanli corrigendumtohighexpressionofdll3isassociatedwithapoorprognosisandimmuneinfiltrationininvasivebreastcancerpatientstranslationaloncology142021101080
AT zunguodu corrigendumtohighexpressionofdll3isassociatedwithapoorprognosisandimmuneinfiltrationininvasivebreastcancerpatientstranslationaloncology142021101080